Equities

Viemed Healthcare Inc

Viemed Healthcare Inc

Actions
  • Price (EUR)6.65
  • Today's Change-0.05 / -0.75%
  • Shares traded0.00
  • 1 Year change-0.75%
  • Beta--
Data delayed at least 15 minutes, as of Sep 19 2024 19:22 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments131728
Total Receivables, Net181515
Total Inventory4.633.572.46
Prepaid expenses2.453.851.73
Other current assets, total------
Total current assets384047
Property, plant & equipment, net776863
Goodwill, net30----
Intangibles, net0.57----
Long term investments3.904.162.16
Note receivable - long term------
Other long term assets0.891.590.86
Total assets155117118
LIABILITIES
Accounts payable7.414.905.25
Accrued expenses158.846.86
Notes payable/short-term debt000
Current portion long-term debt/capital leases1.330.501.94
Other current liabilities, total8.364.623.75
Total current liabilities321918
Total long term debt6.130.204.57
Total debt7.460.696.52
Deferred income tax------
Minority interest------
Other liabilities, total2.740.890.76
Total liabilities412023
SHAREHOLDERS EQUITY
Common stock191514
Additional paid-in capital16127.75
Retained earnings (accumulated deficit)797073
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total--0(0.28)
Total equity1149795
Total liabilities & shareholders' equity155117118
Total common shares outstanding393840
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.